Product nameAnti-ACTL8 antibody - C-terminal
See all ACTL8 primary antibodies
DescriptionRabbit polyclonal to ACTL8 - C-terminal
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Human
Recombinant fragment corresponding to Human ACTL8 (C terminal). Gene Accssion: BC028909
Database link: Q9H568
- HeLa and A549 cell lysates. Human breast cancer tissue.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.3
Preservative: 0.05% Sodium azide
Constituents: 49% PBS, 50% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab197831 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/15 - 1/50.|
|WB||1/500 - 1/2000. Predicted molecular weight: 41 kDa.|
Tissue specificityStrongly expressed in testis and pancreas. Weak expression in placenta.
Sequence similaritiesBelongs to the actin family.
Cellular localizationCytoplasm > cytoskeleton.
- Information by UniProt
- Actin like 8 antibody
- Actin like protein 8 antibody
- Actin like protein antibody
All lanes : Anti-ACTL8 antibody - C-terminal (ab197831) at 1/350 dilution
Lane 1 : HeLa cell lysate
Lane 2 : A549 cell lysate
Lysates/proteins at 40 µg per lane.
Predicted band size: 41 kDa
Exposure time: 5 seconds
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labeling ACTL8 with ab197831 at 1/15 dilution.
ab197831 has not yet been referenced specifically in any publications.